Speaker illustration

Doctor Tabito Kino

Temple University School of Medicine, Philadelphia (United States of America)

A novel optimal medical therapy for preventing secondary cardiovascular events in subjects with coronary artery diseases in Japan.

Event: ESC Congress 2018

Topic: Secondary Prevention

Session: Secondary prevention


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb